Besides, in IBD patients,particularly those who are under anti-TNF-α treatment, the host innate immune systeminterferes more efficiently with viral replication cycle and the clinical presentations aremore moderate (9, 12). The gene discussed is TNF; the disease is inflammatory bowel disease.